Prime Medicine (PRME) Earnings Date & Reports

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRME is expected to report earnings to rise 7.50% to -43 cents per share on August 06

Prime Medicine PRME Stock Earnings Reports

Q2'25

Est.

$-0.43

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.03

The last earnings report on May 08 showed earnings per share of -40 cents, beating the estimate of -43 cents. With 3.24M shares outstanding, the current market capitalization sits at 208.76M.

View a ticker or compare two or three

Compare

PRME